BackFaron Pharmaceuticals Oy Overview

Faron Pharmaceuticals Oy Current Assets

Faron Pharmaceuticals Oy's current assets is $11M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$11.06M
↑ 24.77% YoYΔ $2.20M vs prior year quarter

Peer trimmed avg / median

Loading

Faron Pharmaceuticals Oy Current Assets History

Loading

Faron Pharmaceuticals Oy vs. peers: Current Assets Comparison

Loading

Faron Pharmaceuticals Oy Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Faron Pharmaceuticals Oy (FPHAF) FAQ

Faron Pharmaceuticals Oy (FPHAF) currently reports a current assets of $11M as of December 2024. That compares with $8.9M in the prior-year period — up 24.8% year over year. Use the charts on this page to explore Faron Pharmaceuticals Oy's current assets history and peer comparisons.

Faron Pharmaceuticals Oy's current assets increased from $8.9M to $11M — a 24.8% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Faron Pharmaceuticals Oy reported $11M in current assets as of December 2024. That compares with $8.9M in the prior-year period — up 24.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Faron Pharmaceuticals Oy, and consider following FPHAF for alerts when major investors trade the stock.

Faron Pharmaceuticals Oy is classified in the Healthcare sector. On current assets, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FPHAF with unrelated industries.